News & Updates

Show Multimedia Only

Brexpiprazole improves agitation in Alzheimer’s dementia

09 Nov 2023 by

A double-blind, placebo-controlled, randomized clinical trial reports significant improvement in agitation with brexpiprazole vs placebo among patients with Alzheimer’s dementia.

09 Nov 2023

Brain-controlled ankle prosthesis promotes natural movement, stability

08 Nov 2023 by

Neural control of a robotic ankle prosthesis appears to help its users to employ mechanisms that the body naturally uses to maintain balance and stability, including ankle movements, for better postural control, as shown in a study.

08 Nov 2023

LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo

08 Nov 2023

Use of the lung immune prognostic index (LIPI) score can help predict the efficacy of combination therapy of programmed cell death (PD)-1/PD-ligand 1 (PD-L1) blockade and chemotherapy (CT) in patients with advanced nonsmall cell lung cancer (NSCLC), suggests a study.

08 Nov 2023

Neoadjuvant immunotherapy delivers better response in NSCLC

08 Nov 2023 by

Patients with nonsmall cell lung cancer (NSCLC) who have been treated with neoadjuvant immunotherapy show greater response than those treated with neoadjuvant chemotherapy (CT), as shown in a study. Treatment-related adverse events (TRAEs) are similar between the two groups.

08 Nov 2023

Binge eating, less self-monitoring lead to regain in successful weight losers

08 Nov 2023

Overeating in response to internal and external food cues as well as declines in self-monitoring and body image contribute to weight regain in successful weight losers in a weight-management program, reports a recent study.

08 Nov 2023

Serum vitamin A, E forms tied to prostate cancer risk

08 Nov 2023 by

Several forms of serum vitamin A and E were associated with prostate cancer risk, with significant effect modification by smoking and alcohol consumption status, according to an analysis that used data from the Singapore Prostate Cancer Study.

08 Nov 2023

Original New Drug Application Approvals by US FDA (16-31 October 2023)

08 Nov 2023

New drug applications approved by US FDA as of 16-31 October 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

08 Nov 2023

Catheter ablation beneficial to AF patients with end-stage heart failure

08 Nov 2023

When combined with guideline-directed medical therapy, catheter ablation helps reduce the risk of adverse outcomes such as death, left ventricular assist device implantation, and urgent heart transplantation in patients with atrial fibrillation (AF) and end-stage heart failure, according to data from the CASTLE HTx study.

08 Nov 2023